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Lysophosphatidic acid-induced proliferation in opossum kidney Once initiated, renal failure tends to be relentlessly
proximal tubular cells: Role of PI 3-kinase and ERK. progressive [1], and therapeutic strategies designed to
Background. Lysophosphatidic acid (LPA) is a mitogenic slow or stop this progression have so far been largelylipid bound to albumin in the circulation and implicated in the
ineffective. It is recognized in both animals with experi-induction of proximal tubular cell (PTC) injury in proteinuric
mental renal disease and humans that declining renalstates. In this study, we investigated the effect of LPA on prolifer-
ation of opossum kidney (OK) cells and the roles of the p85/ function correlates most strongly with the pathological
p110 phosphatidylinositol 3-kinase (PI 3-kinase) and extracel- changes seen in the tubulointerstitium of the kidney [2, 3].
lular signal-regulated kinases (ERKs) ERK-1 and ERK-2 in The presence of protein, most notably albumin, in theLPA-induced proliferation.
urine of patients with renal disease has conventionallyMethods. [3H]-thymidine incorporation was used as an index
been regarded simply as a marker of the severity of theof OK cell proliferation. PI 3-kinase and ERK activities were
measured by in vitro kinase assays of immunoprecipitates from disease state. Nonetheless, it is recognized that those
both wild-type OK cells and OK cells expressing a dominant patients with proteinuria are more likely to develop pro-
negative p85 (Dp85) subunit of PI 3-kinase in an inducible gressive renal failure than those without proteinuria [4],vector.
and recently, it has been hypothesized that albuminuriaResults. LPA stimulated a marked increase in [3H]-thymidine
may exert a toxic effect on proximal tubular epithelialuptake in wild-type and Dp85 OK cells. OK cell PI 3-kinase
activity was stimulated by LPA and was inhibited by expression cells (PTECs) in its own right, thereby damaging the
of Dp85. LPA-induced proliferation was inhibited by wortman- cells and initiating the process of interstitial fibrosis and
nin and the induction of Dp85 expression. These data suggest scarring [5–8].that LPA stimulates PI 3-kinase activity, which is essential for
One current theory suggests that the nephrotoxicitysignaling the induction of proliferation. LPA also stimulated
of albuminuric states is not directly determined by theERK activity (peak at 5 min, return to baseline by 60 min)
maximally at a dose of 100 mm LPA. This increase was approxi- protein molecule itself, but that toxicity resides in other
mately 600% above basal and was similar to the effects of 10% molecules, particularly lipids, carried by albumin. Albu-
fetal calf serum. The proliferative effect of LPA was decreased min possesses several fatty acid-binding sites and can beby the ERK-kinase (MEK) inhibitor PD98059 (5 mM), there-
considered as a lipoprotein [9]. Experiments that demon-fore suggesting that ERK as well as PI 3-kinase activation is
strate that proximal tubule segments exposed to fattyimportant for proliferation. ERK activation by LPA was not
affected by pretreatment with wortmannin or by the expression acid bearing albumin, but not fatty acid-free albumin,
of Dp85. PI 3-kinase activation by LPA was not affected by are able to produce a lipid chemoattractant exemplify
pretreatment with PD98059. the potential pathophysiological importance of the lipo-Conclusions. We conclude that activation of PI 3-kinase is
protein like properties of albumin and suggest it has anessential for the LPA-induced proliferation of OK cells and
important role in the development of tubulointerstitialthat ERK activation is also important. Therefore, they are both
vital elements in separate signaling pathways leading to cell inflammation [10].
proliferation. LPA filtered into the proximal tubule in protein- Lysophosphatidic acid (LPA) is an intercellular lipid
uric states is likely to have profound effects on PTC growth. mediator with growth factor-like activities [11, 12]. Albu-
min-bound LPA may account for much of the biological
activity of serum [11]. Platelet aggregation is commonlyKey words: proximal tubule, OK cells, cell signaling, proteinuria,
injury, kinases. observed in the glomerular capillaries in many renal dis-
eases [13], and LPA released by activated platelets isReceived for publication December 1, 1998
likely to enter the proximal tubule when liberated inand in revised form July 20, 1999
Accepted for publication August 3, 1999 the glomerulus either alone or complexed with albumin.
Therefore, it is possible that LPA exerts receptor-medi- 1999 by the International Society of Nephrology
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ated effects on the proximal tubule cells, and it is likely OK cells between passages 60 and 87. All tissue culture
media and chemicals were obtained from Sigma (Poole,that this effect may be of considerable importance in
PTEC pathophysiology. Dorset, UK) unless otherwise stated. Geneticin (G-418)
was from GIBCO Life Technologies (Paisley, UK). Hy-Phosphoinositide (PI) 3-kinases are involved in the
signal transduction of virtually all growth factors studied gromycin, PD98059, and wortmannin were from Calbio-
chem (Nottingham, UK).and in the transformation of cells by several oncoproteins
[14, 15]. The family of PI 3-kinases are divided into three Peptide substrate of epidermal growth factor (EGF)
receptor (RRELVEPLTPSGEAPNQALLR) was frommajor classes: I, II, and III. These distinctions are based
on their amino acid sequence, the degree of homology the PNACL unit (Leicester University). Rabbit poly-
clonal anti–ERK-1 (C16: sc-93) antibody was from Santabetween their lipid-kinase domains, and their substrate
specificities [14]. The class IA PI 3-kinases, which include Cruz Biotech (Wiltshire, UK). Protein-A sepharose
CL-4B was from Pharmacia Biotech (Uppsala, Sweden).at least three isozymes (a, b, and d) are heterodimers
of a catalytic 110 kDa subunit (p110) and a regulatory Anti-active ERK antibody was from Promega (South-
ampton, UK).subunit of 85 or 55 kDa [16]. Indeed, the catalytic subunit
of PI 3-kinase (p110a) has been identified as a retroviral
Cell cultureoncogene [16]. Heterodimeric class IA PI 3-kinase has a
clearly demonstrated and critical role in receptor-medi- Opossum kidney cells were grown as described pre-
viously [31]. OK cells transfected with a dominant nega-ated mitogenesis [17–20].
The mitogen-activated protein (MAP) kinase pathway tive form of the PI 3-kinase p85 subunit (Dp85) using the
LacSwitch expression system were also used in experi-is another key component in the transduction of signals
leading to growth and transformation. This pathway con- ments. The cDNAs encoding bovine Dp85 were kindly
provided by M.D. Waterfield (Ludwig Institute for Can-sists of a linear cascade of the protein kinases Raf, MEK,
and MAP kinase/ERK. Like PI 3-kinase, ERK1 and ERK2 cer Research, London, UK). Details of subcloning, con-
struction of expression plasmids, cell transfection, selec-are acutely activated by growth factors and are found
constitutively activated in many transformed cell lines. tion, and screening of transfected cells have been described
previously [32]. These Dp85 OK cells were maintainedThis kinase activity is up-regulated through phosphoryla-
tion on tyrosine and threonine residues by ERK/extracel- as described earlier in this article for wild-type OK cells
except for the addition of hygromycin 200 mg/ml togetherlular signal-regulated kinase kinases (MEKs) [21, 22].
MEKs are substrates for Raf-1 [23, 24], which has been with G418 300 mg/ml.
reported to be activated through either receptors in-
Preparation of lysophosphatidic acidvolved in Ras or a PKC-dependent pathway [25, 26].
These ERK activators cause the translocation of ERK A stock solution of LPA (oleoyl) was prepared in a
solution (1 mg/ml) of fatty acid-free bovine serum albu-from the cytosol to the nucleus [27, 28], where transcrip-
tion factors such as Elk-1 [29] and c-Ets [30] are substrates min (FAF-BSA; $97% albumin, essentially fatty acid-
free) and distilled water so as to obtain a stock solutionfor ERK. Consequently, ERK serves as an important reg-
ulator of transcriptional activity related to proliferation. of 10 mm LPA [31].
We recently showed that LPA causes a transient in-
3H-thymidine proliferation assaycrease in intracellular calcium ([Ca21]i) and a significant
proliferation in a proximal tubule cell line [opossum kid- Opossum kidney cells were plated in 24 well plates
and grown to approximately 70% confluence. They wereney (OK) cells] [31]. In the current study, we have further
investigated the effects of LPA on the OK cells, focusing then incubated in serum-free and thymidine-free Dul-
becco’s modified Eagle’s medium (DMEM) for 24 hourson the role of PI 3-kinase and ERK activation in the
proliferation of proximal tubule cells. We show that acti- at 378C. The medium was then replaced with fresh serum-
free DMEM alone (control), serum-free DMEM supple-vation of both PI 3-kinase and ERK are essential for
the LPA-induced proliferation of OK cells and that inhi- mented with 10% fetal calf serum (FCS), various con-
centrations of LPA, and various concentrations of fattybition of either does not affect the activation of the other
kinase, indicating separate pathways to induction of pro- acid-free BSA as controls. After an additional 24 hours,
2 mCi of [3H]-thymidine (Amersham Life Science, Littleliferation.
Chalfont, Buckinghamshire, UK) were added to all wells.
In time course experiments, the media containing the
METHODS
agonist were washed out and replaced with serum-free
Materials media and incubated at 378C for the remainder of the
24-hour period. After two hours of incubation with [3H]-Opossum kidney cells are an immortalized cell line
derived from opossum kidneys and were obtained from thymidine, the cells were washed three times with
DMEM and then incubated with 2 ml of ice-cold 5%Dr. J. Caverzasio (Geneva, Switzerland). This study used
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trichloroacetic acid (TCA) for one hour at 48C. The TCA the absence of substrate were subtracted from values
measured in the presence of substrate.was removed, and the cells were washed once with fresh
ice-cold TCA. Then 2 ml of ice-cold ethanol containing
Electrophoresis and immunoblotting200 mm potassium acetate were added to each well for
Treated cells were lyzed in Laemmli buffer (60 mmfive minutes. The cells were then incubated twice in 2
Tris, pH 6.8, 10% glycerol, 2% SDS, 100 mm DTT, andml of 3:1 mixture of ethanol:ether for 15 minutes per
0.01% bromophenol blue) and proteins in cell lysatesincubation. After allowing the cell monolayers to air dry,
were separated by polyacrylamide gel electrophoresiscells were solubilized in 1 ml of 0.1 m sodium hydroxide.
and transferred to nitrocellulose membranes. Anti-active[3H]-thymidine counts per minute (cpm) were measured
ERK antibody, which only reacts with the activated dualby adding samples to scintillation fluid (Ultima Gold;
threonine and tyrosine-phosphorylated p42 and p44Packard, Berkshire, UK) and counted by using a Packard
forms of ERK, was used as the primary antibody at a 11900CA Tri-Carb liquid scintillation analyzer.
in 20,000 dilution. Secondary antibodies were detected
Extracellular signal-regulated kinase using enhanced chemiluminescence (ECL) development.
immunoprecipitation and assay
Phosphatidylinositol 3-kinase assay
Extracellular signal-regulated kinase proteins were
The activity of PI 3-kinase activity was measured in anti-isolated by immunoprecipitation from OK cell lysates
phosphotyrosine immunoprecipitates of both wild-type andand assayed for activity according to the following proce-
Dp85-transfected OK cells by in vitro kinase assay usingdure. After cells had reached confluence, they were se-
phosphatidylinositol (PtdIns) as the substrate as previouslyrum starved for 24 hours prior to the addition of agonists.
described [32, 33]. The [32P]-labeled lipid products of theFollowing stimulation, the cells were solubilized with ice-
kinase reaction were deacylated and separated by high-cold lysis buffer [20 mm Tris-HCl, pH 8.0, 0.5% Nonidet
performance liquid chromatography (HPLC) using a par-P-40, 250 mm NaCl, 3 mm ethylenediaminetetraacetic
tisphere SAX column eluted with a continuous gradientacid (EDTA), 3 mm egtazic acid (EGTA), 1 mm phenyl-
made using water and 1.25 m (NH4)HPO4, pH 3.8. Radio-methansulfonyl fluoride, 2 mm Na3VO4, 20 mg/ml aproti- labeled reaction products were detected using a [32P] flownin, 5 mg/ml leupeptin, and 1 mm dithiothreitol (DTT)].
through detector.Insoluble material was removed from lysates by 10 min-
utes of centrifugation at 14,000 3 g, 48C. Lysates were Statistics
incubated for 90 minutes at 48C with a 1:100 dilution of
Data are given as mean values with the standard error
rabbit polyclonal anti–ERK-1 antiserum (200 mg/ml).
of the mean (sem). For analyzing differences, unpaired
Immune complexes were incubated further for 90 min- two-tailed Student’s t-tests were performed. Differences
utes at 48C with 70 ml of a 15% (vol/vol) slurry of protein were regarded significant at P , 0.05.
A-sepharose and were collected by centrifugation. Im-
munoprecipitates were washed twice in 200 ml lysis
RESULTSbuffer and twice in 200 ml kinase buffer (20 mm HEPES,
pH 7.2, 20 mm b-glycerophosphate, 10 mm MgCl2, 1 mm Characterization of Dp85-transfected opossum
DTT, and 50 mm Na3VO4). Immune complex ERK assays kidney cells
were initiated by the addition of 40 ml of kinase buffer Dp85 transfected OK cells could be induced to express
containing 20 mm [g-32P]ATP (2.5 mCi/nmol) and 200 mm Dp85 protein by exposure to isopropylthiogalactoside
of a synthetic peptide substrate corresponding to amino (IPTG). Expression of the transfected gene was maximal
acids 662 to 681 of the EGF receptor. Reactions were after 18 hours of incubation with 5 mm IPTG. Under
incubated for 20 minutes at 308C and terminated by the these conditions Dp85 was expressed at levels tenfold
addition of 10 ml of 25% (wt/vol) TCA. Mixtures were greater than the endogenous p85, and insulin-stimulated
centrifuged at 14,000 3 g for two minutes and spotted PI 3-kinase activity in anti-phosphotyrosine immunopre-
onto squares of p81 cation exchange paper (Whatman). cipitates was completely inhibited. The results of exten-
Papers were washed four times for five minutes each sive characterization studies of this cell line have been
time with 0.5% (wt/vol) phosphoric acid and were rinsed published previously [32].
once with acetone and dried and counted by adding the
Lysophosphatidic acid stimulates phosphatidylinositolsamples to scintillation fluid. These were counted using
3-kinase activity in opossum kidney cellsa Packard 1900CA Tri-Carb liquid scintillation analyzer.
In each lysate, the ERK kinase measurement was per- Both wild-type and Dp85-transfected OK cells were
formed in duplicate. To correct for nonspecific phosphor- immunoprecipitated under control conditions or after
ylation, in filter paper assays of kinase activity in cytosolic stimulation with 10 mm LPA. In some experiments, cells
were pretreated with 5 mm PD 98059 for 20 minutes priorextracts, levels of phosphate incorporation measured in
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to agonist stimulation. The immunoprecipitates were Dp85 also diminished the mitogenic effect of serum in
these experiments.then used for in vitro assay of PI 3-kinase using PtdIns
as the substrate, and the results are depicted in Figure 1.
Lysophosphatidic acid acts via ERK to induceUnder control conditions, PI 3-kinase activity associated
proliferation in opossum kidney cellswith antiphosphotyrosine was negligible (Fig. 1A). After
stimulation by 10 mm LPA for 10 minutes, PI 3-kinase Using an antibody that detects the active phosphory-
lated form of ERK, lysates of LPA treated OK cellswas stimulated and associated with anti-phosphotyro-
sine, resulting in the production of PtdIns(3)P (Fig. 1B). were separated by polyacrylamide gel electrophoresis
(PAGE) and probed for active ERK using Western blot-This activity was not inhibited by pretreatment with PD
98059 (Fig. 1C). Similarly, in non-IPTG–induced Dp85 ting methods. As can be seen in Figure 3, both ERK-1
(p44) and ERK-2 (p42) show an increase in phosphoryla-cells, LPA stimulated PI 3-kinase (Fig. 1D), but this
activity was completely abolished when cells were in- tion after only 60 seconds of treatment with 10 mm LPA.
There seemed to be a peak of phosphorylation at twoduced to express Dp85 by prior addition of IPTG (Fig.
1E). This pattern of PI 3-kinase activity and inhibition and five minutes in these experiments and significant
phosphorylation even after 15 minutes. To confirm ERKin Dp85 cells was very similar to that observed when
stimulated by insulin in the presence or absence of IPTG activation by LPA, we examined ERK activity by an
immunoprecipitation assay using a synthesized peptide[32]. Pertussis toxin (PTX) pretreatment (50 ng/ml, 18
hr) had no effect on LPA-stimulated PI 3-kinase activity corresponding to a portion of the EGF receptor as a
substrate. Figure 4A shows the time course over which(data not shown).
ERK was activated by 10 mm LPA. The amount of FAF-
Lysophosphatidic acid acts via phosphatidylinositol BSA present in a 10 mm dose of LPA was found to have
3-kinase to cause proliferation of opossum kidney cells no significant effect on ERK activity. ERK activity rose
rapidly after LPA stimulation with similar kinetics toThe effect of LPA on the proliferation of OK cells
was assessed by measuring [3H]-thymidine incorporation ERK phosphorylation (Fig. 3). Incubation with 10 mm
LPA caused an approximately five to six times peakas an index of DNA synthesis. As shown in Figure 2A,
incubation of OK cells with LPA for 24 hours resulted increase in ERK activation at five minutes in these exper-
iments, which then gradually dropped to basal levelsin a dose-dependent increase in thymidine incorporation,
which was found to be maximal at 100 mm LPA, causing after 60 minutes. Figure 4B shows the dose response
data for ERK activation by LPA with the in vitro kinasean increase of 382 6 10% over control cells. As a positive
control, the effect of 10% FCS on proliferation of OK assay. The effect of LPA was concentration dependent
in the range of 1028 to 1023 m, with a calculated EC50 ofcells was studied and was found to stimulate proliferation
comparably to 100 mm LPA (increase of 421 6 19% over 1.5 3 1026 m with 95% confidence intervals 6.5 3 1027
to 3.2 3 1026 m. Again, the amount of FAF-BSA presentcontrol).
The effect of pretreatment of the cells with 100 nm in all concentrations of LPA was found not to have any
effect on ERK activity in this system.wortmannin, a PI 3-kinase inhibitor, shows a consider-
able inhibition of proliferation caused by 100 mm LPA The MEK inhibitor PD98059 was used in experiments
to elucidate whether inhibition of ERK activity in OK(decrease of 330 6 42%) and also partially by 10% FCS.
The method of preparation of LPA prior to its applica- cells would have any effect on LPA induced prolifera-
tion. Figure 5A shows that pretreatment of the cells withtion to the cells (discussed earlier in this article) necessi-
tates its reconstitution in a BSA-containing solution. 50 mm MEK results in a significant reduction in 10 mm
LPA stimulation ERK activation as measured by in vitroTherefore, all experiments involve the obligate exposure
of the cells to not only LPA, but also albumin. Figure kinase assay (decrease in 470 6 15% over control), thus
confirming that the MEK inhibitor did indeed inhibit2A shows the effects of the FAF-BSA controls. For ex-
ample, a dose of 100 mm LPA included FAF-BSA at a ERK activity in the OK cells. Cell viability as assessed
by trypan blue exclusion was greater than 95% in allconcentration of 10 mg/ml. As can be seen from these
data, FAF-BSA caused no significant effect at these con- experiments and showed no significant difference be-
tween the various conditions. Therefore, a brief incuba-centrations. Dixon, Young, and Brunskill show more
detailed dose response curve of proliferation caused by tion of OK cells with PD98059 at concentrations up to
50 mm was not toxic, although clearly inhibited ERKLPA in OK cells [31].
Figure 2B depicts the effect of inducing the expression activation by LPA. The next step was to test whether
inhibition of ERK activity would have an effect on LPA-of Dp85 on LPA-induced proliferation of Dp85 trans-
fected OK cells. It is clear that the effect of 100 mm LPA induced proliferation in these cells. As shown in Figure
5B, 5 mm of PD98059 caused a decrease of 608 6 25%was virtually abolished by Dp85 expression (decrease of
202 6 14%), indicating that PI 3-kinase was vital for of thymidine incorporation over the control compared
with cells treated with 10 mm LPA without prior exposureLPA-induced proliferation in these cells. Expression of
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Fig. 1. The p85/p110 phosphatidylinositol 3-kinase (PI 3-kinase) activity in opossom kidney (OK) cell antiphosphotyrosine immunoprecipitates.
Serum starved, wild-type, and Dp85 OK cells were immunoprecipitated with antiphosphotyrosine antibodies under control conditions (no agonist
stimulation) or after stimulation with 10 mm lysophosphatidic acid (LPA) in the presence or absence of PD98059. The immunoprecipitate was
used for in vitro assay of PI 3-kinase using PtdIns as the substrate. Deacylated [32P]-lipid products were separated by high-performance liquid
chromatography, and representative elution profiles are displayed. (A) In immunoprecipitates from wild-type cells under control conditions, no
appreciable PI 3-kinase activity is observed. (B) When wild-type cells are stimulated with 10 mm LPA, PI 3-kinase activity becomes associated
with tyrosine-phosphorylated proteins and catalyzes the formation of PtdIns(3) as indicated. (C) Preincubation of wild-type cells with 5 mm PD98059
for 20 minutes has no effect on PI 3-kinase activity stimulated by 10 mm LPA. (D) In noninduced Dp85 OK cells, LPA stimulates a similar response
in PI 3-kinase activity. (E) The induction of Dp85 expression by IPTG completely abolishes PI 3-kinase activity in response to 10 mm LPA, the
PtdIns(3)P peak being completely diminished. The elution profiles shown are representative of at least three experiments for each condition.
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to the MEK inhibitor. This clearly indicates the impor-
tance of ERK activity in transmitting the proliferative
signal of LPA to the cells nucleus. Indeed, it seems that
serum used as a positive control also has some of its
proliferative effects diminished due to ERK inhibition,
indicating that ERK is a key element in the signal trans-
duction of proliferation. Note that at the time length
(24 hr) of the proliferation assay, 50 mm PD98059 was
significantly toxic as assessed by trypan blue exclusion.
Therefore, 5 mm of PD98059 were employed in these
experiments and found to be nontoxic.
Lysophosphatidic acid-induced ERK and
phosphatidylinositol 3-kinase activity are not
connected in the same signaling pathway
The observation that LPA activates both PI 3-kinase
and ERK in OK cells to induce proliferation raised the
question as to whether PI 3-kinase was upstream or
downstream of ERK in the intracellular signaling path-
way. To answer this question, we pretreated OK cells
with 100 nm wortmannin to inhibit PI 3-kinase activity,
as in previous experiments, and investigated whether LPA
treatment would still cause ERK activation within the
cells. Figure 6A demonstrates clearly that ERK activation
by 10 mm LPA is not affected by the wortmannin pretreat-
ment. Interestingly, the serum control showed that ERK
activation was considerably sensitive to PI 3-kinase inhibi-
tion, indicating that some of serum’s effects on ERK
proteins are mediated at least in part via PI 3-kinase.
This same result was seen in Dp85 transfected OK cells,
whereby induced expression of Dp85 caused no inhibi-
tion of ERK activation by 10 mm LPA, whereas it reduced
the ERK activity stimulated by the serum control (by
135 6 18; Fig. 6B). To confirm this result further, the
degree of ERK protein phosphorylation induced by LPA
was found to not be affected by expression of the Dp85
subunit in transfected OK cells (Fig. 6C). Thus, the data
clearly indicate that LPA causes activation of ERK inde-
pendent of PI 3-kinase activity, whereas the serum con-
trols exhibit an ERK activation pathway that is sensitive
to PI 3-kinase inhibition.
The next step was to investigate whether PI 3-kinase
stimulation by LPA was sensitive to ERK inhibition by
the PD98059 compound. Figure 1C shows a representa-
Fig. 2. Inhibition of PI 3-kinase blocks LPA-induced proliferation in tive experiment in which PI 3-kinase activity was mea-
OK cells. (A) Serum-starved cells (approximately 70% confluent) were sured using the in vitro kinase assay. Pretreatment of
pretreated ( ) or not (j) with 100 nm wortmannin for 20 minutes.
the cells with 5 mm of the MEK inhibitor caused noCells then washed three times with serum-free media and were stimu-
lated with appropriate agents in serum-free media for 24 hours. (B) decrease in PI 3-kinase stimulation by LPA compared
This shows the effect of LPA on Dp85-transfected OK cells. Dp85 with control cells that were not pretreated with the inhib-
expression was induced by pre-exposure of the cells to 5 mm IPTG for
itor. Therefore, the data clearly suggest that the LPA-18 hours. Control cells were not treated with IPTG. Serum-starved cells
were then treated with appropriate agents in serum-free media for 24 stimulated activity of both PI 3-kinase and ERK is not
hours. The results are presented as percentages 6 sem (derived from closely interconnected and would seem to be members
at least three experiments with four replicates for each condition) of
of separate signaling pathways to proliferation.the control cells, which were incubated with serum-free media. *P ,
0.05; **P , 0.01; ***P , 0.001. These effects on ERK activity by LPA (10 mm) and
FCS (10%) were inhibited 187 6 23% and 371 6 45%,
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Fig. 3. LPA causes an increase in phosphory-
lation of ERK proteins in OK cells. Serum-
starved cells were treated with 10 mm LPA for
various times and were then lyzed. Cell lysates
were resolved by SDS-polyacrylamide electro-
phoresis and blotted with antibodies against
active (phosphorylated) ERK (see Methods
section). This is a representative immunoblot
from three independent experiments.
Fig. 5. PD98059 inhibits LPA-induced ERK activity and proliferation
in OK cells. (A) Serum-starved cells were treated with the appropriate
concentration of PD98059 for 20 minutes and were then incubated with
10 mm LPA, 10% FCS, or serum-free media for five minutes. Cells were
then lyzed, and ERK was activity measured by in vitro kinase assay.
Results are presented as percentages (6 sem, N 5 3) of the control
cells that were incubated with serum-free media. Symbols are: (j)
control; ( ) 50 mm PD; ( ) 5 mm PD; ( ) 500 nm PD. (B) Serum-Fig. 4. LPA causes an increase in ERK activity in OK cells. (A) Serum-
starved OK cells were incubated with 10 mm LPA for varying times. starved cells were pretreated with the indicated concentration of
PD98059 for 20 minutes and were then stimulated with 10 mm LPA,Cells were then lyzed, and ERK activity was measured by in vitro
kinase assay. (B) Serum-starved OK cells were incubated with various 10% FCS, or serum-free media for 24 hours. PD98059 was present
throughout the incubation period. Results are presented as percentagesconcentrations of LPA for five minutes. Cells were then lyzed, and ERK
activity was measured by in vitro kinase assay. Results are presented as (6 sem, N 5 3) of the control cells that were incubated with serum-
free media. Symbols are: (j) control; ( ) 5 mm PD; ( ) 500 nm PD;percentages (6 sem, N 5 3) of the control cells that were incubated
with serum-free media. ( ) 50 nm PD. *P , 0.05; **P , 0.01; ***P , 0.001.
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Fig. 6. LPA-induced ERK activation is not
affected by inhibition of PI 3-kinase. (A) Se-
rum-starved cells were pretreated ( ) or not
(j) with 100 nm wortmannin for 20 minutes
and were then stimulated with appropriate
agent for five minutes. Cells were then lyzed
and ERK activity was measured by in vitro
kinase assay. (B) The effect of LPA on ERK
activity in Dp85-transfected OK cells. Symbols
are: (j) control; ( ) IPTG pretreated. Dp85
expression was induced by pre-exposure of
the cells to 5 mm IPTG for 18 hours. Serum-
starved cells were then treated with appro-
priate agents in serum-free media for five min-
utes. Cells were then lyzed, and ERK activity
was measured by in vitro kinase assay. Results
are presented as percentages (6 sem, N 5 3)
of the control cells that were incubated with
serum-free media. *P , 0.05. (C) Dp85-trans-
fected OK cells were pretreated with IPTG
and were serum starved. Cells were treated
with 10 mm LPA for various times and were
then lyzed. Cell lysates were resolved by SDS-
PAGE and blotted with antibodies against ac-
tive (phosphorylated) ERK. This is a repre-
sentative immunoblot from three independent
experiments.
respectively, by PTX pretreatment (50 ng/ml, 18 hr; Fig. 7). Hence, these data strongly suggest the involvement of a
In contrast, PTX pretreatment had no effect on the in- PTX-sensitive G-protein–linked receptor in mediating
crease in ERK activity response to 100 ng/ml EGF, which the activation of ERK by LPA in OK cells. In contrast,
acted through a tyrosine kinase receptor. The absence of it may be that the activation of PI 3-kinase by LPA in
a PTX effect on EGF-induced ERK activation excluded these cells is mediated through a different system.
nonspecific toxicity of this treatment as an explanation
for the PTX inhibition of LPA-induced ERK activation.
DISCUSSIONUsing the in vitro PI 3-kinase assay, it was found that
The pathophysiology of progressive renal scarring inPTX pretreatment had no effect on the LPA (10 mm)
induced increase in PI 3-kinase activity (data not shown). renal disease is poorly understood, but is likely to be
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present in albumin-bound form. Extracellular LPA can
also be generated through secretory phospholipase A2
acting on microvesicles shed from blood cells challenged
with inflammatory stimuli [37], suggesting that one of
the in vivo functions of LPA is to stimulate proliferative
responses at sites of injury and inflammation.
The effects of LPA on proximal tubule cell growth
were investigated in our previous studies [31], in which
we found LPA to be a potent mitogen (EC50 5 1025 m),
for OK cells, a proximal tubule cell line [38] whose re-
sponse was also highly PTX sensitive. Using this func-
tional response of these cells to LPA, we went on to
study the roles played by PI 3-kinase and ERK in the
signal transduction events involved in proliferation, be-
cause derangements of proximal tubule cell growth have
been implicated in the progression of renal disease [39].
Indeed, we have recently demonstrated increased turn-
over of PTEC in proteinuria manifest as an increase in
both proliferative and apoptotic rate of these cells [40].
The mediators signaling these changes in cell growth and
survival are unclear.Fig. 7. Pertussis toxin (PTX) pretreatment inhibits LPA-induced ERK
activity in OK cells. OK cells were pretreated for 18 hours with 50 ng/ml The results presented here show that both PI 3-kinase
PTX and then stimulated with agonists for five minutes. Cells then lysed and ERK are clearly activated in OK cells by exposureand ERK activity was measured by in vitro kinase assay. Results are
to LPA. Using the potent PI 3-kinase inhibitor, wortman-presented as percentages (6 sem, N 5 3) of the control cells, which
were incubated with serum-free media. Symbols are: (j) no PTX; ( ) nin, and a dominant negative PI 3-kinase p85 subunit,
PTX pretreatment; *P , 0.05; **P , 0.01. our experiments reveal that LPA-induced proliferation
is highly sensitive to PI 3-kinase inhibition. Inhibition of
ERK with the MEK inhibitor PD98059 also blocked
proliferation, although not completely. Because of themultifactorial. The powerful association between pro-
teinuria, tubulointerstitial scarring, and renal disease time length of the proliferation assay (24-hr incubation
with agonist), it was found that exposure of the cells toprogression has led to the hypothesis that either protein-
uria per se or some other unidentified bioactivity in ne- a dose of 50 mm PD98059 was toxic. Therefore, the dose
had to be decreased to 5 mm, at which there was nophrotic glomerular ultrafiltrate may play an important
role in the development of renal scarring and inflamma- significant toxicity. At this concentration, PD98059 in-
hibits approximately half of the ERK activity in the cellstion [34, 35]. It is notable, therefore, that associated with
the filtered protein are large quantities of lipid material and also substantially inhibits the mitogenic effects of
LPA. ERK does not appear to be upstream of PI 3-kinasethat enter the proximal tubule in large part complexed
with albumin. Lipid molecules can be presented to proxi- because its inhibition with the PD 98059 compound did
not affect PI 3-kinase stimulation by LPA.mal tubule cells at concentrations far in excess of their
maximum solubility by virtue of their capacity to bind Lysophosphatidic acid-induced activation of ERK was
not affected by prior inhibition of PI 3-kinase with eitherto albumin, and indeed, intracellular lipid droplets in
PTECs are a prominent feature of proteinuric states [36]. wortmannin or Dp85, suggesting that LPA can activate
ERK independently of PI 3-kinase and that these twoIn view of the paucity of knowledge regarding lipid
signaling in the proximal tubule, the aim of our study pathways are both separate, but individually vital for LPA
induction of proliferation.was to investigate the effects of potentially important
lipid mediators on proximal tubular cell (PTC) function. In order to judge the potency of the LPA proliferative
response, we used 10% serum as a positive control forLPA was a particularly attractive candidate to examine
because it is likely to be liberated in substantial quantities comparison. Interestingly and in contrast to LPA, 10%
serum-induced ERK activation was considerably, but notin inflamed glomeruli and, subsequently, is very likely
to enter the proximal tubule together with albumin. LPA completely, reduced by maneuvers, which inhibited PI
3-kinase, thus indicating that in part the mitogenic effectis rapidly produced and released from activated platelets
and influences target cells by activating a specific G-pro- of serum signals the activation of ERK via PI 3-kinase.
A considerable number of bioactive growth factors intein–coupled receptor that is present in numerous cell
types [11]. As a product of the blood clotting system, serum are likely to have a synergistic mitogenic effect
in cell culture and typically would be expected to signalLPA is an abundant constituent of serum where it is
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via tyrosine kinase stimulation. At least one of these such that the EGF receptor is an intermediate in mito-
genic signaling by LPA in L cells [52]. Very recently, aagents therefore must stimulate proliferation of OK cells
model has been formulated that allows transactivationvia a pathway dissimilar from that of LPA.
of receptor tyrosine kinases by activated Gi- and Gq/11-A number of studies have used wortmannin or domi-
linked receptors [53]. This paradigm proposes that occu-nant negative forms of PI 3-kinase to address the involve-
pation of a Gi- or Gq/11-coupled receptor by an agonistment of this enzyme in the regulation of the ERK path-
such as LPA can result in transactivation of one or sev-way. The results of these studies conflict; although
eral receptor tyrosine kinases. The mechanism of thisseveral have found that wortmannin [41–46] or domi-
transactivation process remains unclear, but certainly, itnant-negative PI 3-kinase [47] effectively inhibit activa-
is possible to envisage that in OK cells, LPA signalingtion of the ERK kinase cascade, others have found that
through a G-protein–coupled receptor may be linked viainhibition of PI 3-kinase has no effect on the activation
Gi to MAP kinase activation, and in a PTX-insensitiveof ERK proteins [48–50].
manner, via Gq/11 to transactivation of a receptor tyrosineThe results of our study clearly indicate that both ERK
kinase. This activated receptor tyrosine kinase wouldactivation and PI 3-kinase activation are required for
then be able to stimulate type IA PI 3-kinase activityLPA-stimulated proliferation of OK cells. However,
according to conventional understanding as demon-only the ERK response to LPA is sensitive to PTX, and
strated in this current study.inhibition of ERK does not inhibit PI 3-kinase, and vice
Despite the finding that ERK and PI 3-kinase areversa. Hence, PI 3-kinase is not required for ERK activa-
activated by exclusive means in OK cells, activity of bothtion, and neither is ERK activity required for PI 3-kinase
pathways is required for LPA’s proliferative effect tostimulation. This particular relationship between ERK
be fully manifest. ERK has been shown to stimulateand PI 3-kinase activities has not been observed in every
transcriptional activity via phosphorylation of the ter-system studied. Duckworth and Cantley have suggested
nary complex factor, Elk-1 [54]. On the other hand, athat ERK activity may be dependent on PI 3-kinase
downstream effector of PI 3-kinase activation is the ribo-under conditions of low physiological agonist concentra-
somal p70 S6 kinase that is responsible in part for regula-tion or low receptor number, but that if higher agonist
tion of mRNA translational activity [55]. It is temptingconcentrations are employed, ERK can be activated via
to speculate that both increased transcription and trans-a redundant pathway not involving PI 3-kinase [33].
lation are required for OK cells to co-ordinate a prolifer-Physiological (10 mm) concentrations of LPA used in
ative response to LPA and, hence, the requirement forthese studies, however, do not support this contention.
both ERK and PI 3-kinase activities. More work is re-Indeed, if a tenfold higher concentration of LPA is em-
quired, however, to confirm this hypothesis.
ployed in identical experiments, exactly the same rela- A number of functions of PTCs have been identified
tionship between ERK and PI 3-kinase activities is ob- that suggest that they can take part in the process of
served (results not shown). inflammation and scarring. These functions include the
A natural question that follows from these observa- production of matrix proteins, proinflammatory cyto-
tions relates to the mechanism of stimulation by LPA kines, and chemotactic substances [5]. This is not surpris-
of these two separate kinase systems. As a lipid signaling ing considering that embryologically they are derived
molecule, LPA differs from previously identified peptide from mesenchymal cells, as are fibroblasts and the cells
growth factors, which exert their actions through recep- of the immune system [56]. Our evidence suggests that
tor tyrosine kinases. Recently, a number of receptors for lipids such as LPA may directly modulate tubular cell
LPA have been cloned that belong to the family of G-pro- function, altering both their growth characteristics, and
tein–coupled receptors [12, 51]. Signaling of LPA through possibly phenotype. As discussed earlier in this article,
receptor tyrosine kinases has not been described. It considerable circumstantial evidence places LPA in the
seems likely in the light of these results that LPA is able proximal tubule in proteinuric glomerular diseases. It is
to activate ERK in a PTX sensitive manner through a interesting to speculate that in addition to a role in con-
Gai-linked receptor in OK cells via Ras and Raf as has trol of cell proliferation, a further consequence of LPA
been previously described [12]. The mechanism of PTX- signaling within the proximal tubule epithelium may be
insensitive activation of PI 3-kinase by LPA is less clear. the production of proinflammatory substances such as
The type IA PI 3-kinase responsible for LPA-induced growth factors and cytokines [57]. This issue is the subject
proliferation in OK cells is not classically activated by of ongoing research in our laboratory, as is the develop-
G-protein–coupled receptors. Rather, tyrosine-phosphor- ment of an assay to quantitate LPA in human patients’
ylated receptor tyrosine kinases are thought to activate urine.
this class of PI 3-kinase via interaction with the SH2
domain of the p85 regulatory subunit. It is relevant there- ACKNOWLEDGMENTS
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